Primary disorders of muscles
Notes: Autosomal recessive, childhood type, muscular dystrophy resembling Duchenne or Becker muscular dystrophy ; Benign [Becker] muscular dystrophy ; Severe [Duchenne] muscular dystrophy ; Scapulohumeral muscular dystrophy ; LGMD D4 calpain-3-related ; LGMD D5 collagen 6-related ; Limb girdle muscular dystrophy type 1 ; Limb girdle muscular dystrophy type 2A ; LGMD R1 calpain-3-related ; Primary calpainopathy ; Dysferlinopathy ; LGMD R2 dysferlin-related ; Limb girdle muscular dystrophy type 2B ; Miyoshi Myopathy type 1 ; Sarcoglycanopathy, NOS ; Alpha sarcoglycanopathy ; Limb-girdle muscular dystrophy due to alpha-sarcoglycan deficiency ; Limb girdle muscular dystrophy type 2D ; Beta sarcoglycanopathy ; Limb girdle muscular dystrophy due to beta-sarcoglycan deficiency ; Limb girdle muscular dystrophy type 2E ; Delta sarcoglycanopathy ; Delta-sarcoglycan-related LGMD R6 ; Gamma sarcoglycanopathy ; Gamma-sarcoglycan-related LGMD R5 ; Limb girdle muscular dystrophy type 2C ; Limb girdle muscular dystrophy type 2F ; Anoctamin-5-related LGMD R12 ; Anoctaminopathy ; Autosomal recessive limb girdle muscular dystrophy type 2L ; Miyoshi myopathy type 3 ; LGMD R9 FKRP-related ; LGMD R22 collagen 6-related ; Limb girdle muscular dystrophy due to fukutin related protein dysfunction ; Limb girdle muscular dystrophy type 2I ; Other autosomal recessive limb girdle muscular dystrophy ; Benign scapuloperoneal muscular dystrophy with early contractures [Emery-Dreifuss] ; Congenital muscular dystrophy NOS ; Congenital muscular dystrophy with specific morphological abnormalities of the muscle fiber ; Distal muscular dystrophy ; Ocular muscular dystrophy ; Oculopharyngeal muscular dystrophy ; Scapuloperoneal muscular dystrophy ; Dystrophia myotonica [Steinert] ; Myotonia atrophica ; Myotonic dystrophy ; Proximal myotonic myopathy (PROMM) ; Steinert disease ; Acetazolamide responsive myotonia congenita ; Dominant myotonia congenita [Thomsen disease] ; Myotonia levior ; Recessive myotonia congenita [Becker disease] ; Chondrodystrophic myotonia ; Congenital myotonic chondrodystrophy ; Schwartz-Jampel disease ; Myotonia fluctuans ; Myotonia permanens ; Neuromyotonia [Isaacs] ; Paramyotonia congenita (of von Eulenburg) ; Pseudomyotonia ; Symptomatic myotonia ; Myotubular (centronuclear) myopathy ; Autosomal centronuclear myopathy ; Autosomal dominant centronuclear myopathy ; Autosomal recessive centronuclear myopathy ; Centronuclear myopathy, NOS ; Central core disease ; Minicore disease ; Multicore disease ; Multiminicore disease ; Hereditary myopathy NOS ; code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) ; Kearns-Sayre syndrome (H49.81) ; Leber’s disease (H47.21) ; Leigh’s encephalopathy (G31.82) ; mitochondrial metabolism disorders (E88.4.-) ; Reye’s syndrome (G93.7) ; arthrogryposis multiplex congenita (Q74.3) ; metabolic disorders (E70-E88) ; myositis (M60.-) ; arthrogryposis multiplex congenita (Q74.3)